Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
JDRF
Biotech
GentiBio banks $157M to fuel Treg treatment for Type 1 diabetes
GentiBio raised $157 million to advance a regulatory T cell treatment for Type 1 diabetes toward the clinic.
Amirah Al Idrus
Aug 11, 2021 6:00am
IM Therapeutics' lead diabetes candidate posts positive results
Jul 21, 2021 8:00am
JDRF, IQVIA partner on Type 1 diabetes diagnostics research
Jul 20, 2020 10:40am
Biolinq raises an extra $4.75M to trial its painless CGM patch
Apr 1, 2019 10:25am
ImmusanT to move into Type 1 diabetes with JDRF backing
Sep 11, 2018 8:00am
Canada’s Inversago raises $7M to target cannabinoid receptors
Jul 25, 2018 9:54am
